ProfessorJamie Triccas
Professor and Deputy Director, Sydney Infectious Diseases Institute
Faculty of Medicine and Health
Orcid identifier0000-0003-3730-2339 (opens in a new tab)
- Professor and Deputy Director, Sydney Infectious Diseases InstituteFaculty of Medicine and Health
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONA computational approach to identify determinants of immunological protection against Betacoronaviruses of pandemic potential
- RESEARCH-BASED DEGREE SUPERVISIONCharacterization of the Pseudomonas aeruginosa acetylome using multi-omic approaches
- RESEARCH-BASED DEGREE SUPERVISIONComparing next generation vaccine platforms
- RESEARCH-BASED DEGREE SUPERVISIONCyclic Peptide Inhibitors of Coagulation Proteases as Novel Therapeutic Leads
- RESEARCH-BASED DEGREE SUPERVISIONDeciphering the mucosal immunological response to novel vaccines for respiratory pathogens
- RESEARCH-BASED DEGREE SUPERVISIONDefining and optimising protective immune responses for mRNA vaccines against M. tuberculosis
- RESEARCH-BASED DEGREE SUPERVISIONDesign, Synthesis and Evaluation of Cyclic Peptide Bromodomain Inhibitors
- RESEARCH-BASED DEGREE SUPERVISIONDeveloping therapeutics and vaccines for biofilm-forming bacterial pathogens
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment and preclinical assessment of old and new vaccine candidates against Mycobacterium abscessus
- RESEARCH-BASED DEGREE SUPERVISIONInvestigating the immunogenicity of novel vaccine adjuvants for protection against respiratory pathogens
- RESEARCH-BASED DEGREE SUPERVISIONMulti-omics analysis of host adaptation by Pseudomonas aeruginosa during Cystic Fibrosis infection to inform whole-protein vaccine identification
- RESEARCH-BASED DEGREE SUPERVISIONNovel subunit and live vaccine strategies to protect against tuberculosis
- RESEARCH-BASED DEGREE SUPERVISIONThe Recruitment and Transcriptional Profile of Tuberculosis Vaccine-Induced Lung Resident Memory T Cells
- RESEARCH-BASED DEGREE SUPERVISIONUnderstanding pathogenicity and immune responses against Mycobacterium abscessus: implications for vaccine design